 |
|
|
| |
Bioequivalence of a Fixed-Dose Combination of
Rilpivirine/Emtricitabine/Tenofovir Alafenamide to
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide and Rilpivirine
|
| |
| |
Reported by Jules Levin
15th European AIDS Conference, October 21-24, 2015, Barcelona, Spain
Julia Zack, Eileen Doyle, Hiba Graham, Mona Vimal, Steve West, Erin Quirk
Gilead Sciences, Inc., Foster City, California, USA
|
| |
|
|
|
|
|
